NO932097L - Myke farmasoeytiske kapsler som inneholder lysinclonixinat og fremgangsmaate for deres fremstilling - Google Patents
Myke farmasoeytiske kapsler som inneholder lysinclonixinat og fremgangsmaate for deres fremstillingInfo
- Publication number
- NO932097L NO932097L NO932097A NO932097A NO932097L NO 932097 L NO932097 L NO 932097L NO 932097 A NO932097 A NO 932097A NO 932097 A NO932097 A NO 932097A NO 932097 L NO932097 L NO 932097L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- methods
- capsules containing
- containing lysine
- pharmaceutical capsules
- Prior art date
Links
- 239000002775 capsule Substances 0.000 title abstract 2
- CVNFYQCHAWFYQI-ZSCHJXSPSA-N clonixin lysine salt Chemical compound NCCCC[C@H](N)C(O)=O.CC1=C(Cl)C=CC=C1NC1=NC=CC=C1C(O)=O CVNFYQCHAWFYQI-ZSCHJXSPSA-N 0.000 title 1
- 229960003763 lysine clonixinate Drugs 0.000 title 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
- 239000002202 Polyethylene glycol Substances 0.000 abstract 2
- 239000007903 gelatin capsule Substances 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- 229920001223 polyethylene glycol Polymers 0.000 abstract 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 230000004968 inflammatory condition Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4219702A DE4219702A1 (de) | 1992-06-16 | 1992-06-16 | Pharmazeutische Weichkapseln enthaltend Lysinclonixinat und ein Verfahren zu dessen Herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO932097D0 NO932097D0 (no) | 1993-06-09 |
| NO932097L true NO932097L (no) | 1993-12-17 |
Family
ID=6461132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO932097A NO932097L (no) | 1992-06-16 | 1993-06-09 | Myke farmasoeytiske kapsler som inneholder lysinclonixinat og fremgangsmaate for deres fremstilling |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0574822A1 (ko) |
| JP (1) | JPH0665078A (ko) |
| KR (1) | KR940000108A (ko) |
| CN (1) | CN1037934C (ko) |
| AU (1) | AU656078B2 (ko) |
| CA (1) | CA2098410A1 (ko) |
| DE (1) | DE4219702A1 (ko) |
| FI (1) | FI932768A (ko) |
| IE (1) | IE930446A1 (ko) |
| IL (1) | IL105870A (ko) |
| MX (1) | MX9303582A (ko) |
| NO (1) | NO932097L (ko) |
| ZA (1) | ZA934222B (ko) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19849848A1 (de) * | 1998-10-29 | 2000-05-04 | Lohmann Therapie Syst Lts | Oral applizierbare, mit Flüssigkeit spontan zerfallende therapeutische Darreichungsform und Verfahren zu ihrer Herstellung |
| KR20030042935A (ko) * | 2001-11-26 | 2003-06-02 | 알앤피코리아 주식회사 | 클로닉신리신 제제 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3337570A (en) * | 1965-10-23 | 1967-08-22 | Schering Corp | Substituted nicotinic acids and method for the manufacture thereof |
| US4141976A (en) * | 1976-01-05 | 1979-02-27 | The Regents Of The University Of Michigan | Process for alleviating proliferative skin diseases |
| DE4037554A1 (de) * | 1990-11-26 | 1992-05-27 | Roemmers Sa | Arzneimittel zur topischen anwendung |
-
1992
- 1992-06-16 DE DE4219702A patent/DE4219702A1/de not_active Withdrawn
-
1993
- 1993-06-01 IL IL10587093A patent/IL105870A/en not_active IP Right Cessation
- 1993-06-03 AU AU40009/93A patent/AU656078B2/en not_active Ceased
- 1993-06-09 NO NO932097A patent/NO932097L/no unknown
- 1993-06-09 EP EP93109279A patent/EP0574822A1/de not_active Ceased
- 1993-06-10 KR KR1019930010541A patent/KR940000108A/ko not_active Application Discontinuation
- 1993-06-11 JP JP5166129A patent/JPH0665078A/ja active Pending
- 1993-06-15 MX MX9303582A patent/MX9303582A/es not_active Application Discontinuation
- 1993-06-15 ZA ZA934222A patent/ZA934222B/xx unknown
- 1993-06-15 CA CA002098410A patent/CA2098410A1/en not_active Abandoned
- 1993-06-15 IE IE044693A patent/IE930446A1/en not_active IP Right Cessation
- 1993-06-16 FI FI932768A patent/FI932768A/fi unknown
- 1993-06-16 CN CN93107267A patent/CN1037934C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU656078B2 (en) | 1995-01-19 |
| EP0574822A1 (de) | 1993-12-22 |
| KR940000108A (ko) | 1994-01-03 |
| IL105870A (en) | 1996-12-05 |
| MX9303582A (es) | 1994-04-29 |
| CN1083702A (zh) | 1994-03-16 |
| DE4219702A1 (de) | 1993-12-23 |
| ZA934222B (en) | 1994-01-17 |
| CA2098410A1 (en) | 1993-12-17 |
| FI932768A0 (fi) | 1993-06-16 |
| AU4000993A (en) | 1993-12-23 |
| IE930446A1 (en) | 1993-12-29 |
| CN1037934C (zh) | 1998-04-08 |
| IL105870A0 (en) | 1993-10-20 |
| NO932097D0 (no) | 1993-06-09 |
| FI932768A (fi) | 1993-12-17 |
| JPH0665078A (ja) | 1994-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Parsons | Epithelial coating techniques in the treatment of interstitial cystitis | |
| AU681452B2 (en) | Pernasal composition and pernasal preparation containing thesame | |
| ES2036221T3 (es) | Procedimiento para preparar una composicion de l-dopa de dosis unitaria multiple. | |
| MY111260A (en) | Pharmaceutical composition for the treatment of nicotine dependence | |
| IE63182B1 (en) | Instant oral-release capsule containing nifedipine | |
| Rowe et al. | Control of pain resulting from endodontic therapy: a double-blind, placebo-controlled study | |
| AU2003218130A8 (en) | N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors | |
| NO932097L (no) | Myke farmasoeytiske kapsler som inneholder lysinclonixinat og fremgangsmaate for deres fremstilling | |
| BG60101B2 (bg) | Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол | |
| EP0689437B1 (en) | Use of granisetron for the treatment of post-operative nausea and vomiting | |
| FI962056A (fi) | Uusi farmaseuttinen koostumus stabiilin jauheen valmistamiseksi, joka sisältää asetyylisalisyylihapon ja metoklopramidin yhdistelmän käsittävän aktiivisen aineosan | |
| US5741807A (en) | Histidine compositions and methods for treating or preventing infectious and non-infectious diarrheas | |
| RU97107418A (ru) | Углеводные производные, фармацевтическая композиция на их основе | |
| US4794112A (en) | Acetaminophen/hydroxyzine analgesic combinations | |
| Mahler et al. | Assay of aspirin and naproxen analgesia | |
| Smolin et al. | Combined gentamicin-tobramycin-corticosteroid treatment: II. Effect on gentamicin-resistant Pseudomonas keratitis | |
| US5679713A (en) | Pharmaceutical composition containing carbachol and other cholinergic substances | |
| ATE212550T1 (de) | Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung | |
| FI932654A0 (fi) | Hydroxamsyraderivat, som hindrar lipoxigenas | |
| Silvestri | Ichthyosiform dermatosis and deafness | |
| Roath | Management of Raynaud’s phenomenon: focus on newer treatments | |
| CN107753490A (zh) | 一种治疗肿瘤放疗所致口腔黏膜炎的透皮给药制剂 | |
| KR900004340A (ko) | 의약제 | |
| US20220339175A1 (en) | Application of Stachyose in Preparation of Drug for Treating Castration-Resistant Prostate Cancer | |
| EP0254693A1 (en) | Pharmaceutical form for enteric administration of etodolic acid or its salts, in admixture with excipients |